This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2016 Jan;15(1):16-7.

doi: 10.1038/nrd.2015.40.

Cancer: Engineered T cells gain access to pancreatic tumours

Alexandra Flemming

PMID: 26718277
DOI: 10.1038/nrd.2015.40

Comment

Cancer: Engineered T cells gain access to pancreatic tumours

Alexandra Flemming. Nat Rev Drug Discov. 2016 Jan.

. 2016 Jan;15(1):16-7.

doi: 10.1038/nrd.2015.40.

Author

Alexandra Flemming

PMID: 26718277
DOI: 10.1038/nrd.2015.40

No abstract available

PubMed Disclaimer

Comment on

T Cells Engineered against a Native Antigen Can Surmount Immunologic and Physical Barriers to Treat Pancreatic Ductal Adenocarcinoma.
Stromnes IM, Schmitt TM, Hulbert A, Brockenbrough JS, Nguyen H, Cuevas C, Dotson AM, Tan X, Hotes JL, Greenberg PD, Hingorani SR. Stromnes IM, et al. Cancer Cell. 2015 Nov 9;28(5):638-652. doi: 10.1016/j.ccell.2015.09.022. Epub 2015 Oct 29. Cancer Cell. 2015. PMID: 26525103 Free PMC article.

References

1. Cancer Cell. 2015 Nov 9;28(5):638-52 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Medical
- MedlinePlus Health Information